Kerala Ayurveda Revises Preferential Share Issue

Total consideration of Rs 12.47 crore through issuance of 655,000 equity shares.
Issue price set at Rs 190.37 per share, including a premium of Rs 180.37.

Reader Takeaway: Conversion of debt improves balance sheet strength, while promoter holding increases to 9.41% stake.

What just happened

Kerala Ayurveda Limited has issued a corrigendum regarding its proposed preferential issue to promoter group entity Katra Holding Private Limited. The company board approved a reduction in the number of equity shares to be issued, lowering the count from the originally proposed 720,000 to 655,000. The price per share remains fixed at Rs 190.37, determined in compliance with SEBI (ICDR) regulations using August 28, 2026, as the relevant date.

Why this matters

The primary objective of this issuance is to strengthen the financial position of the company. By converting part of an existing unsecured loan provided by Katra Holding into equity, Kerala Ayurveda aims to reduce its overall debt exposure and improve its net worth. This transaction directly impacts the company's capital structure without requiring cash outflow.

Shareholding Impact

Post-allotment, the stake held by Katra Holding in Kerala Ayurveda will increase on an actual basis from 4.85% to 9.41%. On a fully diluted basis, the promoter group's shareholding will rise from 4.57% to 8.89%. The company has explicitly stated that this transaction will not result in any change in management or control of the firm.

Risks and Compliance

The shares issued will be subject to a 90-day lock-in period following the receipt of trading approval. The company confirms that it, along with its promoters and directors, is in full compliance with listing requirements and has not been categorized as a willful defaulter or fraudulent borrower.

What to track next

Shareholders will vote on this special resolution during the 34th Annual General Meeting scheduled for Monday, September 28, 2026.